MedTrace Logo

Improvement of a Digital Health Platform for Remote Monitoring of Patients With Heart Failure

NCT05708846 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 154

Last updated 2025-04-09

Study results available
· View outcomes & findings →

Summary

In the present project, we propose to run an observational study in order to create a huge dataset with telemonitoring data from heart failure (HF) patients. The dataset will contain physiological measurements, socio-demographic data, risk factor information, medication tracking, symptomatology, clinical events and health-related questionnaire answers from each patient. Furthermore, health-related alarms will be delivered to the medical professionals whenever a measure from a patient is out of a predefined clinical range. These alarms and its defined level of relevance (indicated by the medical professionals) will also be Included in the dataset. With the annotated dataset we will be able to implement and train Machine Learning (ML) models that will improve the alarm-based system by making it more robust, trustworthy and reliable.

Conditions

Interventions

OTHER

Telemonitoring

All patients will be telemonitored in order to create a labeled and diverse dataset that will include the following data: Physiological parameters (measured periodically), socio-demographic data, risk factors, medication tracking, symptomatology questionnaire for patients, NYHA-class, clinical interventions, health questionnaire answers, classified alarms with their respective timestamp and annotation by the MD, and measurement ranges for each personalized alarm and their changes

Sponsors & Collaborators

  • European Innovation Council

    collaborator OTHER

  • Hospital Universitario de Torrevieja

    collaborator UNKNOWN

  • University of Barcelona

    collaborator OTHER

  • humanITcare

    lead NETWORK

Principal Investigators

  • Julio César MD Blázquez · Hospital Universitario de Torrevieja

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-18
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Romania
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05708846 on ClinicalTrials.gov